These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10617083)

  • 81. Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro.
    Teng G; Ju Y; Yang Y; Hua H; Chi J; Mu X
    Mol Med Rep; 2016 Dec; 14(6):5164-5170. PubMed ID: 27840931
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Identification of novel nitroreductases from Bacillus cereus and their interaction with the CB1954 prodrug.
    Gwenin VV; Poornima P; Halliwell J; Ball P; Robinson G; Gwenin CD
    Biochem Pharmacol; 2015 Dec; 98(3):392-402. PubMed ID: 26415543
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Crystal structure of FMN-dependent nitroreductase from Escherichia coli B: a prodrug-activating enzyme.
    Parkinson GN; Skelly JV; Neidle S
    J Med Chem; 2000 Oct; 43(20):3624-31. PubMed ID: 11020276
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase.
    Ball P; Thompson E; Anderson S; Gwenin V; Gwenin C
    Eur J Pharm Sci; 2019 Jan; 127():217-224. PubMed ID: 30414836
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?
    Nawa A; Tanino T; Luo C; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Nishiyama Y; Kikkawa F
    Anticancer Agents Med Chem; 2008 Feb; 8(2):232-9. PubMed ID: 18288924
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
    Palmer DH; Mautner V; Mirza D; Oliff S; Gerritsen W; van der Sijp JR; Hubscher S; Reynolds G; Bonney S; Rajaratnam R; Hull D; Horne M; Ellis J; Mountain A; Hill S; Harris PA; Searle PF; Young LS; James ND; Kerr DJ
    J Clin Oncol; 2004 May; 22(9):1546-52. PubMed ID: 15051757
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The nitroreductase/CB1954 enzyme-prodrug system.
    Green NK; Kerr DJ; Mautner V; Harris PA; Searle PF
    Methods Mol Med; 2004; 90():459-77. PubMed ID: 14657579
    [No Abstract]   [Full Text] [Related]  

  • 88. Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.
    Chung-Faye G; Palmer D; Anderson D; Clark J; Downes M; Baddeley J; Hussain S; Murray PI; Searle P; Seymour L; Harris PA; Ferry D; Kerr DJ
    Clin Cancer Res; 2001 Sep; 7(9):2662-8. PubMed ID: 11555577
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT.
    Tietze LF; Schmuck K
    Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425
    [TBL] [Abstract][Full Text] [Related]  

  • 90. NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation.
    Sharrock AV; Mulligan TS; Hall KR; Williams EM; White DT; Zhang L; Emmerich K; Matthews F; Nimmagadda S; Washington S; Le KD; Meir-Levi D; Cox OL; Saxena MT; Calof AL; Lopez-Burks ME; Lander AD; Ding D; Ji H; Ackerley DF; Mumm JS
    Nat Methods; 2022 Feb; 19(2):205-215. PubMed ID: 35132245
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prodrugs in genetic chemoradiotherapy.
    Patterson AV; Saunders MP; Greco O
    Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Chemotherapeutic tumour targeting using clostridial spores.
    Minton NP; Mauchline ML; Lemmon MJ; Brehm JK; Fox M; Michael NP; Giaccia A; Brown JM
    FEMS Microbiol Rev; 1995 Oct; 17(3):357-64. PubMed ID: 7576773
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.
    Chen L; Waxman DJ
    Curr Pharm Des; 2002; 8(15):1405-16. PubMed ID: 12052216
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Engineering the
    Sharrock AV; McManaway SP; Rich MH; Mumm JS; Hermans IF; Tercel M; Pruijn FB; Ackerley DF
    Front Pharmacol; 2021; 12():701456. PubMed ID: 34163368
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
    Leu YL; Chen CS; Wu YJ; Chern JW
    J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prodrugs in cancer chemotherapy.
    Connors TA; Knox RJ
    Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Enhanced cell-specific ablation in zebrafish using a triple mutant of Escherichia coli nitroreductase.
    Mathias JR; Zhang Z; Saxena MT; Mumm JS
    Zebrafish; 2014 Apr; 11(2):85-97. PubMed ID: 24428354
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Development of novel selective cell ablation in the mammary gland and brain to study cell-cell interactions and chemoprevention.
    Gusterson BA; Cui W; Clark AJ
    Recent Results Cancer Res; 2003; 163():31-45; discussion 264-6. PubMed ID: 12903841
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
    de Groot FM; van Berkom LW; Scheeren HW
    J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene.
    Searle PF; Weedon SJ; McNeish IA; Gilligan MG; Ford MJ; Friedlos F; Springer CJ; Young LS; Kerr DJ
    Adv Exp Med Biol; 1998; 451():107-13. PubMed ID: 10026858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.